MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Effects of MRI-guided Focused Ultrasound unilateral subthalamotomy on characteristics of EMG activity underlying reaction time and tapping test in Parkinson’s disease

    D. Urso, B. Fernández-Rodríguez, R. Rodríguez-Rojas, M. del Álamo, F. Hernández-Fernández, J. Pineda-Pardo, M. Dileone, G. Foffani, I. Obeso, C. Gasca-Salas, L. Vela, R. Martínez-Fernández, F. Alonso-Frech, J. Obeso (Móstoles, Spain)

    Objective: To assess the effect of MRI-guided Focused Ultrasound (MRIgFUS) unilateral subthalamotomy on Parkinson disease’s (PD) motor features through EMG movement analysis. Background: Recent evidence…
  • 2018 International Congress

    Long Term Outcome of the Subthalamic Nucleus DBS for Advanced Parkinson’s Disease: An Eight Years Follow-Up Study in China

    Q. Guo, J. Liu, C. Yang, W. Xian, L. Jiang, S. Xu, W. Chen, Y. Hu, L. Chen (Guangzhou, China)

    Objective: To investigate the long term efficacy and its safety of STN DBS for PD in China with an eight years follow up of ten…
  • 2018 International Congress

    Surgery-, hardware – and chronic stimulation-related adverse events following subthalamic nucleus deep brain stimulation for Parkinson’s disease

    B. Gonenli Kocer, E. Ozturk, S. Comoglu, M. Sorar, H. Kertmen (Ankara, Turkey)

    Objective: To evaluate the adverse events (AEs) following subthalamic nucleus (STN) deep brain stimulation (DBS) for Parkinson’s disease (PD) during 6 years period. Background: The…
  • 2018 International Congress

    Impact of changes in resistance on current delivered in constant voltage DBS stimulator in Parkinson’s Disease

    S. Meka, T. Syed, S. Kumar, S. Tandra, R. Kandadai, S. Turaga, R. Borgohain (Hyderabad, India)

    Objective: To assess change in resistance and current with voltage and rate changes in Parkinson’s Disease (PD) patients on DBS therapy. Background: Currently we use…
  • 2018 International Congress

    Toe dystonia in Parkinson’s disease: Impact of subthalamic nucleus deep brain stimulation

    C. Laurencin, S. Montaut, T. Danaila, C. Vial, S. Thobois (Lyon, France)

    Objective: To analyze the prevalence and the evolution of toe dystonia in parkinson's disease (PD) patients candidate to subthalamic nucleus deep brain stimulation (STN-DBS). Background:…
  • 2018 International Congress

    Vitamin B3 and Neurodevelopment in Parkinson’s Disease

    A. Williams, S. Griffin, R. Fricker (Birmingham, United Kingdom)

    Objective: This study aimed to investigate the potential of vitamin B3 to promote the conversion of stem cells to mature central nervous system (CNS) neurons.…
  • 2018 International Congress

    Intensive speech rehabilitation in degenerative ataxias improves intelligility

    A. Vogel, N. Rommel, M. Synofzik (Melbourne, Australia)

    Objective: To test the efficacy and tolerability of intensive home based treatment for dysarthria in ataxia Background: The loss of the ability to speak is…
  • 2018 International Congress

    Genotype-phenotype correlations in 104 Uzbekish families with Spinocerebellar ataxias

    F. Rakhimov, Y. Majidova, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Spinocerebellar ataxias are neurodegenerative disorders involving the cerebellum and its connections. There are more than 30 distinct subtypes, 16 of which are associated with…
  • 2018 International Congress

    Novel CACNA1A gene mutation in a Taiwan family with episodic ataxia type 2

    KF. Chen, CH. Tsai, DC. Wu (Taichung, Taiwan)

    Objective: To illustrate a family of episodic ataxia type 2 with atypical presentations and a novel mutation of CACNA1A gene Background: The episodic ataxias (EAs)…
  • 2018 International Congress

    Under three seconds: Objective speech markers of ataxia in Multiple Sclerosis

    G. Noffs, F. Boonstra, S. Kolbe, A. Evans, H. Butzkeuven, T. Perera, A. Walt, A. Vogel (Melbourne, Australia)

    Objective: To examine the relationship between objective markers of speech motor control, disease severity and ataxia. Background: Mild dysarthria is a common symptom of Multiple…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley